ArabFinance: Arab Drug Company (ADCI) recorded a net profit before tax of EGP 74.21 million during the first seven months of fiscal year (FY) 2021/2022, according to the company’s financial indicators filed to the Egyptian Exchange (EGX).

This marks a decline from the net profit before tax of EGP 86.07 million recorded in the corresponding period of FY 2020/2021.

Moreover, the company generated a net sale of EGP 329.61 million in the seven-month period ended January 31^st 2022, compared to EGP 335.56 million in the same period of FY 2020/2021.

Arab Drug is an Egypt-based company engaged in the pharmaceutical sector. The company focuses on the manufacture, packaging, and distribution of pharmaceutical products as well as chemical solutions for human and veterinary use.